136 related articles for article (PubMed ID: 7909871)
41. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
[TBL] [Abstract][Full Text] [Related]
42. Multiple mutations of the p53 gene in human mammary carcinoma.
Meng L; Lin L; Zhang H; Nassiri M; Morales AR; Nadji M
Mutat Res; 1999 Dec; 435(3):263-9. PubMed ID: 10606817
[TBL] [Abstract][Full Text] [Related]
43. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Thorlacius S; Börresen AL; Eyfjörd JE
Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
[TBL] [Abstract][Full Text] [Related]
44. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
van Slooten HJ; van De Vijver MJ; Borresen AL; Eyfjörd JE; Valgardsdóttir R; Scherneck S; Nesland JM; Devilee P; Cornelisse CJ; van Dierendonck JH
J Pathol; 1999 Dec; 189(4):504-13. PubMed ID: 10629550
[TBL] [Abstract][Full Text] [Related]
45. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
Lasky T; Silbergeld E
Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
[TBL] [Abstract][Full Text] [Related]
46. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
47. Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations.
Franco N; Picard SF; Mege F; Arnould L; Lizard-Nacol S
Cancer Res; 2001 Nov; 61(21):7955-8. PubMed ID: 11691818
[TBL] [Abstract][Full Text] [Related]
48. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
Tsuda H; Iwaya K; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903
[TBL] [Abstract][Full Text] [Related]
49. Mutations in p53, p53 protein overexpression and breast cancer survival.
Rossner P; Gammon MD; Zhang YJ; Terry MB; Hibshoosh H; Memeo L; Mansukhani M; Long CM; Garbowski G; Agrawal M; Kalra TS; Gaudet MM; Teitelbaum SL; Neugut AI; Santella RM
J Cell Mol Med; 2009 Sep; 13(9B):3847-57. PubMed ID: 19602056
[TBL] [Abstract][Full Text] [Related]
50. p53 mutations in breast cancer.
Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
[TBL] [Abstract][Full Text] [Related]
51. The role of p53 mutations in bilateral breast carcinoma.
Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
[TBL] [Abstract][Full Text] [Related]
52. Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan.
Sasa M; Kondo K; Komaki K; Uyama T; Morimoto T; Monden Y
Breast Cancer Res Treat; 1993 Sep; 27(3):247-52. PubMed ID: 8312582
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of p53 gene alterations in node-negative breast cancer.
Elledge RM; Fuqua SA; Clark GM; Pujol P; Allred DC; McGuire WL
Breast Cancer Res Treat; 1993; 26(3):225-35. PubMed ID: 8251647
[TBL] [Abstract][Full Text] [Related]
54. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer.
Tsuda H; Hirohashi S
Int J Cancer; 1994 May; 57(4):498-503. PubMed ID: 7910151
[TBL] [Abstract][Full Text] [Related]
55. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives.
Lohmann D; Ruhri C; Schmitt M; Graeff H; Höfler H
Diagn Mol Pathol; 1993 Mar; 2(1):36-41. PubMed ID: 8287224
[TBL] [Abstract][Full Text] [Related]
56. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
Habuchi T; Takahashi R; Yamada H; Ogawa O; Kakehi Y; Ogura K; Hamazaki S; Toguchida J; Ishizaki K; Fujita J
Cancer Res; 1993 Aug; 53(16):3795-9. PubMed ID: 8339293
[TBL] [Abstract][Full Text] [Related]
57. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
58. [p53 gene mutations of familial breast cancer and early-onset breast cancer in part population of southern China].
Hu X; Ouyang H; Wang H; Li H; Chen F; Dai X; Zhou W; Hu Y; Xue Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):493-500. PubMed ID: 28626092
[TBL] [Abstract][Full Text] [Related]
59. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
[TBL] [Abstract][Full Text] [Related]
60. p53 molecule as a prognostic marker in human malignancies.
Munshi A; Byrne P; Ramesh R; Freeman SM; Marrogi AJ
J La State Med Soc; 1998 Apr; 150(4):175-8. PubMed ID: 9610072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
